SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-139057
Filing Date
2020-05-11
Accepted
2020-05-11 16:14:37
Documents
74
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d915045d10q.htm 10-Q 476343
2 EX-10.4 d915045dex104.htm EX-10.4 13674
3 EX-31.1 d915045dex311.htm EX-31.1 7272
4 EX-31.2 d915045dex312.htm EX-31.2 7281
5 EX-32.1 d915045dex321.htm EX-32.1 4914
  Complete submission text file 0001193125-20-139057.txt   4224011

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT orgo-20200331.xml EX-101.INS 807793
7 XBRL TAXONOMY EXTENSION SCHEMA orgo-20200331.xsd EX-101.SCH 48330
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orgo-20200331_cal.xml EX-101.CAL 51340
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orgo-20200331_def.xml EX-101.DEF 262630
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20200331_lab.xml EX-101.LAB 391797
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20200331_pre.xml EX-101.PRE 347253
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37906 | Film No.: 20864941
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences